Literature DB >> 18561994

The paradoxical effects of vitamin D on type 1 mediated immunity.

Margherita T Cantorna1, Sanhong Yu, Danny Bruce.   

Abstract

Low vitamin D status is associated with an increased risk of Th1 mediated autoimmune diseases like inflammatory bowel disease. 1,25(OH)(2)D(3) treatments have been shown to suppress Th1 mediated immunity and protect animals from experimental autoimmunity. Th1 mediated immunity is important for clearance of a number of different infectious diseases. For tuberculosis 1,25(OH)(2)D(3) treatment is associated with decreased Th1 mediated immunity but increased bactericidal activity. Systemic candidiasis is unaffected by 1,25(OH)(2)D(3) treatment. The seemingly paradoxical effects of 1,25(OH)(2)D(3) and vitamin D on Th1 mediated autoimmunity versus infectious immunity point to a broad array of vitamin D targets in the immune system. The interplay of these vitamin D targets and their impact on the host-immune response then dictate the outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561994      PMCID: PMC2633636          DOI: 10.1016/j.mam.2008.04.004

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  58 in total

1.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 2.  Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease.

Authors:  Margherita T Cantorna
Journal:  Prog Biophys Mol Biol       Date:  2006-02-28       Impact factor: 3.667

Review 3.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis.

Authors:  M Vidyarani; P Selvaraj; M S Jawahar; P R Narayanan
Journal:  Cytokine       Date:  2007-10-29       Impact factor: 3.861

5.  Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.

Authors:  Stefan Falk; Juergen Kratzsch; Ralf Paschke; Christian A Koch
Journal:  Med Sci Monit       Date:  2007-11

6.  Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease.

Authors:  Martin Hewison; Fiona Burke; Katie N Evans; David A Lammas; David M Sansom; Philip Liu; Robert L Modlin; John S Adams
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03       Impact factor: 4.292

7.  Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.

Authors:  Jan Ehrchen; Laura Helming; Georg Varga; Bastian Pasche; Karin Loser; Matthias Gunzer; Cord Sunderkötter; Clemens Sorg; Johannes Roth; Andreas Lengeling
Journal:  FASEB J       Date:  2007-06-05       Impact factor: 5.191

8.  Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Authors:  Jean-Michel Hougardy; Sammy Place; Marc Hildebrand; Annie Drowart; Anne-Sophie Debrie; Camille Locht; Francoise Mascart
Journal:  Am J Respir Crit Care Med       Date:  2007-05-31       Impact factor: 21.405

9.  Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.

Authors:  Monica Froicu; Margherita T Cantorna
Journal:  BMC Immunol       Date:  2007-03-30       Impact factor: 3.615

10.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis.

Authors:  James P Scott-Browne; Shahin Shafiani; Glady's Tucker-Heard; Kumiko Ishida-Tsubota; Jason D Fontenot; Alexander Y Rudensky; Michael J Bevan; Kevin B Urdahl
Journal:  J Exp Med       Date:  2007-08-20       Impact factor: 14.307

View more
  50 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

Review 2.  Role of nutrients in the development of neonatal immune response.

Authors:  Susanna Cunningham-Rundles; Hong Lin; Deborah Ho-Lin; Ann Dnistrian; Barrie R Cassileth; Jeffrey M Perlman
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

3.  Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.

Authors:  L Yazmalar; L Ediz; M Alpayci; O Hiz; M Toprak; I Tekeoglu
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

Review 4.  Current evidence for vitamin D in intestinal function and disease.

Authors:  Mohammadhossein Hassanshahi; Paul H Anderson; Cyan L Sylvester; Andrea M Stringer
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-31

5.  Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.

Authors:  Sulggi A Lee; Joel A Mefford; Yong Huang; John S Witte; Jeffrey N Martin; David W Haas; Paul J Mclaren; Taisei Mushiroda; Michiaki Kubo; Helen Byakwaga; Peter W Hunt; Deanna L Kroetz
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

Review 6.  Classical and emerging roles of vitamin D in hepatitis C virus infection.

Authors:  Julio A Gutierrez; Neil Parikh; Andrea D Branch
Journal:  Semin Liver Dis       Date:  2011-12-21       Impact factor: 6.115

7.  Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults.

Authors:  James R Sabetta; Paolo DePetrillo; Ralph J Cipriani; Joanne Smardin; Lillian A Burns; Marie L Landry
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  Vitamin d and serum cytokines in a randomized clinical trial.

Authors:  Eleanor Yusupov; Melissa Li-Ng; Simcha Pollack; James K Yeh; Mageda Mikhail; John F Aloia
Journal:  Int J Endocrinol       Date:  2010-08-12       Impact factor: 3.257

Review 9.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.

Authors:  Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

10.  Immune changes in post-menopausal osteoporosis: the Immunos study.

Authors:  V Breuil; M Ticchioni; J Testa; C H Roux; P Ferrari; J P Breittmayer; C Albert-Sabonnadière; J Durant; F De Perreti; A Bernard; L Euller-Ziegler; G F Carle
Journal:  Osteoporos Int       Date:  2009-10-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.